These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4006306)

  • 1. Plasma membrane antigens on light density and activated human blood eosinophils.
    Tai PC; Bakes DM; Barkans JR; Spry CJ
    Clin Exp Immunol; 1985 May; 60(2):427-36. PubMed ID: 4006306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies to human eosinophil plasma membrane antigens enhance the secretion of eosinophil cationic protein.
    Tai PC; Capron M; Bakes DM; Barkans J; Spry CJ
    Clin Exp Immunol; 1986 Mar; 63(3):728-37. PubMed ID: 3708911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinophil membrane antigens: phenotypic frequencies in normal individuals and patients with the hypereosinophilic syndrome.
    Tai PC; Spry CJ; Bakes DM; Barkans JR
    Int Arch Allergy Appl Immunol; 1985; 77(1-2):249-51. PubMed ID: 4008080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered density, metabolism and surface receptors of eosinophils in eosinophilia.
    Winqvist I; Olofsson T; Olsson I; Persson AM; Hallberg T
    Immunology; 1982 Nov; 47(3):531-9. PubMed ID: 7129529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [An anti-human eosinophil monoclonal antibody AE500 that reacts only with granulocytes from hypereosinophilic patients].
    Ochiai K; Iwamoto I; Kimura A; Nakagawa N; Tomioka H; Yoshida S; Takahashi H; Yoshida A
    Arerugi; 1990 May; 39(5):459-64. PubMed ID: 2393351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzymes altering the binding capacity of human blood eosinophils for IgG antibody-coated erythrocytes (EA).
    Tai PC; Spry CJ
    Clin Exp Immunol; 1980 Apr; 40(1):206-19. PubMed ID: 6993078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of lacto-N-fucopentaose III (CD15)- and sialyl-Lewis X-bearing molecules and their functional properties in eosinophils from patients with the idiopathic hypereosinophilic syndrome.
    Satoh T; Knowles A; Li MS; Sun L; Tooze JA; Zabucchi G; Spry CJ
    Immunology; 1994 Oct; 83(2):313-8. PubMed ID: 7835953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of an anti-eosinophil monoclonal antibody that recognizes granulocytes from patients with blood eosinophilia but not from subjects without eosinophilia.
    Ochiai K; Iwamoto I; Takahashi H; Yoshida S; Nakagawa N; Tomioka H; Yoshida S
    Clin Exp Immunol; 1991 May; 84(2):283-8. PubMed ID: 2025954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme-linked immunosorbent assay and flow cytometric methods to screen hybridoma culture supernatants for antibodies to bovine neutrophil surface antigens, and monoclonal antibody production and characterization.
    Salgar SK; Paape MJ; Alston-Mills B
    Am J Vet Res; 1993 Sep; 54(9):1415-25. PubMed ID: 8239127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of CD69 expression on peripheral eosinophils in episodic angioedema and eosinophilia.
    Kawano M; Muramoto H; Tsunoda S; Koni I; Mabuchi H; Yachie A; Miyawaki T
    Am J Hematol; 1996 Sep; 53(1):43-5. PubMed ID: 8813097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional CD137 receptors are expressed by eosinophils from patients with IgE-mediated allergic responses but not by eosinophils from patients with non-IgE-mediated eosinophilic disorders.
    Heinisch IV; Bizer C; Volgger W; Simon HU
    J Allergy Clin Immunol; 2001 Jul; 108(1):21-8. PubMed ID: 11447378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective priming of peripheral blood eosinophils in patients with idiopathic hypereosinophilic syndrome.
    Lampinen M; Oberg G; Venge P; Carlson M
    APMIS; 2006 Nov; 114(11):757-63. PubMed ID: 17078855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of degranulation of easily mobilizable intracellular granules by human phagocytes in healthy subjects and patients with infectious diseases.
    Nuutila J; Jalava-Karvinen P; Hohenthal U; Laitinen I; Kotilainen P; Rajamäki A; Nikoskelainen J; Lilius EM
    Hum Immunol; 2009 Oct; 70(10):813-9. PubMed ID: 19559743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rebound eosinophilia after treatment of hypereosinophilic syndrome and eosinophilic gastroenteritis with monoclonal anti-IL-5 antibody SCH55700.
    Kim YJ; Prussin C; Martin B; Law MA; Haverty TP; Nutman TB; Klion AD
    J Allergy Clin Immunol; 2004 Dec; 114(6):1449-55. PubMed ID: 15577851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating eosinophils in asthma, allergic rhinitis, and atopic dermatitis lack morphological signs of degranulation.
    Malm-Erjefält M; Greiff L; Ankerst J; Andersson M; Wallengren J; Cardell LO; Rak S; Persson CG; Erjefält JS
    Clin Exp Allergy; 2005 Oct; 35(10):1334-40. PubMed ID: 16238793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eosinophilia in children. Cytochemical and immunological analysis of increased eosinophils.
    Ishii E; Mizuno Y; Hara T; Okamura J; Aoki T; Kanehara Y; Suda M; Takeshita M; Kikuchi M; Ueda K
    Am J Pediatr Hematol Oncol; 1987; 9(4):308-13. PubMed ID: 3439581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased portal tract infiltration of mast cells and eosinophils in primary biliary cirrhosis.
    Nakamura A; Yamazaki K; Suzuki K; Sato S
    Am J Gastroenterol; 1997 Dec; 92(12):2245-9. PubMed ID: 9399763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms for eosinophil degranulation; release of the eosinophil cationic protein.
    Winqvist I; Olofsson T; Olsson I
    Immunology; 1984 Jan; 51(1):1-8. PubMed ID: 6317543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-5 mRNA levels in blood and bone marrow mononuclear cells from patients with the idiopathic hypereosinophilic syndrome.
    Satoh T; Sun L; Li MS; Spry CJ
    Immunology; 1994 Oct; 83(2):308-12. PubMed ID: 7835952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-2 primes eosinophil degranulation in hypereosinophilia and Wells' syndrome.
    Simon HU; Plötz S; Simon D; Seitzer U; Braathen LR; Menz G; Straumann A; Dummer R; Levi-Schaffer F
    Eur J Immunol; 2003 Apr; 33(4):834-9. PubMed ID: 12672048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.